Notably, a recent secondary analysis of the COMBINE data set showed a blood pressure reduction during treatment in those subjects who were above the median blood pressure at baseline (Stewart et al., 2008). This effect was similar regardless of age, sex, BMI, reported history of hypertension and use of anti-hypertensive medications (Stewart et al., 2008).
